Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina Tbk's quarterly common stock
stayed the same
from Dec. 2025 (Rp307,319 Mil) to Mar. 2026 (Rp307,319 Mil) and
stayed the same
from Mar. 2026 (Rp307,319 Mil) to Jun. 2026 (Rp307,319 Mil).
PT Medikaloka Hermina Tbk's annual common stock
increased
from Dec. 2023 (Rp300,697 Mil) to Dec. 2024 (Rp307,319 Mil) but then
stayed the same
from Dec. 2024 (Rp307,319 Mil) to Dec. 2025 (Rp307,319 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Common Stock of Rp307,319 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PT Medikaloka Hermina Tbk and its competitors.
Is PT Medikaloka Hermina Tbk's Common Stock too high?
PT Medikaloka Hermina Tbk's current Common Stock is Rp307,319 Mil. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Common Stock compare to HCA and THC?
PT Medikaloka Hermina Tbk's Common Stock of Rp307,319 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PT Medikaloka Hermina Tbk and its competitors. PT Medikaloka Hermina Tbk's current Common Stock is Rp307,319 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,559.32, compared to a current price of Rp760.00 — trading 51.3% below its estimated fair value. The current Common Stock is Rp307,319 Mil. PT Medikaloka Hermina Tbk's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Common Stock is Rp307,319 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp760.00 is trading 51.3% below its estimated GF Value™ of Rp1,559.32.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Common Stock: Rp307,319 Mil
GF Value™: Rp1,559.32 vs. price of Rp760.00 (51.3% below fair value)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
68GF Score
Get the complete analysis for ISX:HEAL
Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
